Eichenbaum DA, Holekamp N, Khanani AM, Pieramici D, et al. Reply to Comment on Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration. Am J Ophthalmol 2025 May 7:S0002-9394(25)00229.
PMID: 40345358